The TGF-β type II receptor in chronic myeloid leukemia: Analysis of microsatellite regions and gene expression

Leukemia

Volumn 13, Issue 4, 1999, Pages 535-541

  Rooke, H M ^a   Vitas, M R ^a   Crosier, P S ^a   Crosier, K E ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

CML; Microsatellite instability; TGF

Indexed keywords

MESSENGER RNA; MICROSATELLITE DNA; RIBONUCLEASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DISEASE COURSE; GENE EXPRESSION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MICROSATELLITE INSTABILITY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; RIBONUCLEASE PROTECTION ASSAY; THROMBOCYTHEMIA;

EID: 0032915794     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401384     Document Type: Article

References (39)

1. Kurzrock R, Gutterman JU, Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. New Engl J Med 1988; 319: 990-998.
2. Goldman JM. Chronic myeloid leukemia. Curr Opin Hematol 1997; 4: 277-285.
3. Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, Gishizky ML. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 1993; 75: 175-185.
4. dok: a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 1997; 88: 197-204.
5. Yarnanashi Y, Baltimore D. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell 1997; 88: 205-211.
6. BCR/ABL to the phosphatidylinositol-3′ kinase pathway. Oncogene 1996; 12: 839-846.
7. CAS forms a signaling complex with the adaptor protein CRKL in hematopoietic cells transformed by the BCR-ABL oncogene. J Biol Chem 1996; 271: 25198-25203.
8. Sânchez-García I, Grütz G. Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2. Proc Nat Acad Sci USA 1995; 92: 5287-5291.
9. Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale PK, Groffen J. Acute leukemia in bcr/abl transgenic mice. Nature 1990; 344: 251-253.
10. Cortes JE, Talpaz M, Kantarjian H. Chronic myelogenous leukemia: a review. Am J Med 1996; 100: 555-570.
11. Zeleznik-Le NJ, Nucifora G, Rowley JD. The molecular biology of myeloproliferative disorders as revealed by chromosomal abnormalities. Semin Hematol 1995; 32: 201-219.
12. HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia. Blood 1995; 86: 1916-1923.
13. Reitmair AH, Schmits R, Ewel A, Bapat B, Redston M, Mitri A, Waterhouse P, Mittrücker H-W, Wakeman A, Liu B, Thomason A, Griesser H, Gallinger S, Ballhausen WG, Fishel R, Mak TW. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet 1995; 11: 64-70.
14. Inokuchi K, Ikejima M, Watanabe A, Nakajima E, Orimo H, Nomura T, Shimada T. Loss of expression of the human MSH3 gene in hematological malignancies. Biochem Biophys Res Commun 1995; 214: 171-179.
15. DeCoteau JF, Lowsky R, Curtis J, Ichinohasama R, Dong W-F, Xu Y, Henry M, Minden MD. A germline substitution in trie human MSH2 gene is associated with acute myeloid leukemia and precursor T-lymphoblastic lymphoma/leukemia. 38th Annual Meeting of the American Society of Hematology, Orlando, Florida. Blood 1996; 88: 667a.
16. Hangaishi A, Ogawa S, Mitani K, Hosoya N, Chiba S, Yazaki Y, Hirai H. Mutations and loss of expression of a mismatch repair gene, hMLH1, in leukemia and lymphoma cell lines. Blood 1997; 89: 1740-1747.
17. Wada C, Shionoya S, Fujino Y, Tokuhiro H, Akahoshi T, Uchida T, Ohtani H. Genomic instability of microsatellite repeats and its association with the evolution of chronic myelogenous leukemia. Blood 1994; 83: 3449-3456.
18. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson JKV. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995; 268: 1336-1338.
19. Parsons R, Myeroff LL, Liu B, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res 1995; 55: 5548-5550.
20. Myeroff LL, Parsons R, Kim S-J, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K, Bang Y-J, Lee HY, Park J-G, Lynch HT, Roberts AB, Vogelstein B, Markowitz SD. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 1995; 55: 5545-5547.
21. Imai Y, Tsurutani N, Oda H, Inoue T, Ishikawa T. Genetic instability and mutation of the TGF-beta-receptor-II gene in ampullary carcinomas, Intl J Cancer 1998; 76: 407-411.
22. Izumoto S, Arita N, Ohnishi T, Hiraga S, Taki T, Tomita N, Ohue M, Hayakawa T. Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas. Cancer Lett 1997; 112: 251-256.
23. Keller JR, McNiece IK, Sill KT, Ellingsworth LR, Quesenberry PJ, Sing GK, Ruscetti FW. Transforming growth factor β directly regulates primitive murine hematopoietic cell proliferation. Blood 1990; 75: 596-602.
24. Hayashi S-I, Gimble JM, Henley A, Ellingsworth LR, Kincade PW. Differential effects of TGF-β1 on lymphohemopoiesis in long-term bone marrow cultures. Blood 1989; 74: 1711-1717.
25. Avanzi GC, Lista P, Giovinazzo B, Miniero R, Saglio G, Benetton G, Coda R, Cattoretti G, Pegoraro L. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. Br J Haematol 1988; 69: 359-366.
26. Chen LL, Dean A, Jenkinson T, Mendelsohn J. Effect of transforming growth factor-β1 on proliferation and induction of hemoglobin accumulation in K-562 cells. Blood 1989; 74: 2368-2375.
27. Fafeur V, Terman BI, Blum J, Böhlen P. Basic FGF treatment of endothelial cells down-regulates the 85-KDa TGF-β receptor sub-type and decreases the growth-inhibitory response to TGF-β. Growth Factors 1990; 3: 237-245.
28. Okamoto A, Jiang W, Kim S-J, Spillare EA, Stoner GD, Weinstein IB, Harris CC. Overexpression of human cyclin D1 reduces the transforming growth factor β (TGF-β) type II receptor and growth inhibition by TGF-β1 in an immortalised human esophageal cell line. Proc Nat Acad Sci USA 1994; 91: 11576-11580.
29. Silly H, Chase A, Mills KI, Apfelbeck U, Sormann S, Goldman JM, Cross NCP. No evidence for microsatellite instability or consistent loss of heterozygosity at selected loci in chronic myeloid leukemia blast crisis. Leukemia 1994; 8: 1923-1928.
30. Mori N, Takeuchi S, Tasaka T, Lee S, Spira S, Ben-Yehuda D, Mizoguchi H, Schiller G, Koeffler HP. Absence of microsatellite instability during the progression of chronic myelocytic leukemia. Leukemia 1997; 11: 151-152.
31. Gartenhaus R, Johns MM III, Wang P, Rai K, Sidransky D. Mutator phenotype in a subset of chronic lymphocytic leukemia. Blood 1996; 87: 38-41.
32. Lowsky R, DeCoteau JF, Reitmair AH, Ichinohasama R, Dong W-F, Xu Y, Mak TW, Kadin ME, Minden MD. Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of Rhombotin-2 (Lmo-2) and Tal-1 (SCL). Blood 1997; 89: 2276-2282.
33. Molenaar JJ, Gérard B, Chambon-Pautas C, Cave H, Duval M, Vilmer E, Grandchamp B. Microsatellite instability and frameshift mutations in BAX and transforming growth factor-β RII genes are very uncommon in acute lymphoblastic leukemia in vivo but not in cell lines. Blood 1998; 92: 230-233.
34. Kadin ME, Cavaille-Coll MW, Gertz R, Massagué J, Cheifetz S, George D. Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc Natl Acad Sci USA 1994; 91: 6002-6006.
35. Capocasale RJ, Lamb RJ, Vonderheid EC, Fox FE, Rook AH, Nowell PC, Moore JS. Reduced surface expression of transforming growth factor receptor β type II in mitogen-activated T cells from Sézary patients. Proc Natl Acad Sci USA 1995; 92: 5501-5505.
36. Douglas RS, Capocasale RJ, Lamb RJ, Nowell PC, Moore JS. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-β. Blood 1997; 89: 941-947.
37. Kretzschmar M, Massagué J. SMADs: mediators and regulators of TGF-β signaling. Curr Opin Genet Dev 1998; 8: 103-111.
38. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271: 350-353.
39. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui L-C, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL, Attisano L. MADR2 maps to 18q21 and encodes a TGF-β-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 1996; 86: 543-552.